Buruli ulcer: A systemic disease

被引:47
作者
Pszolla, N
Sarkar, MR
Strecker, W
Kern, P
Kinzl, L
Meyers, WM
Portaels, F
机构
[1] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium
[2] Kreiskrankenhaus Blaubeuren, Chirurg Abt, Blaubeuren, Germany
[3] Univ Ulm Klinikum, Abt Unfallchirurg Hand & Wiederherstellungschirur, Ulm, Germany
[4] Univ Ulm Klinikum, Sekt Infektiol & Klin Immunol, Ulm, Germany
[5] Klinikum Bamberg, Chirurg Klin 2, Bamberg, Germany
[6] Armed Forces Inst Pathol, Washington, DC 20306 USA
关键词
D O I
10.1086/377170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied a 4-year-old boy from Angola who presented with 2 cutaneous ulcerations of the right hip and osteomyelitis of the left knee and right ankle. Mycobacterium ulcerans disease was confirmed by direct smear examination and by polymerase chain reaction. The patient was treated with antimycobacterial drugs, repeated surgical debridement, skin grafting, and daily hyperbaric oxygenation. Despite significant improvement of the local lesions in response to hyperbaric oxygenation, swelling of the right knee, without associated skin lesions, was noted. Radiological evaluation and open biopsy revealed extensive metaphyseal osteomyelitis of the right distal femur. A (99)technetium bone scan revealed an additional focus in the diaphysis of the left humerus, without soft-tissue involvement. This case documents, for the first time ( to our knowledge), the systemic spread of M. ulcerans, with subsequent multifocal osteomyelitis and secondary involvement of soft tissues and supports the hypothesis that low tissue oxygen levels promote hematogenous spread of M. ulcerans. Sickle cell anemia, with associated microthrombosis and microinfarction, may have contributed to tissue hypoxia.
引用
收藏
页码:E78 / E82
页数:5
相关论文
共 18 条
  • [1] Abalos F M, 2000, Ann Diagn Pathol, V4, P386, DOI 10.1053/adpa.2000.19372
  • [2] AGUIAR J, 1997, ARSOM B SEANCES, V3, P325
  • [3] Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice
    Bentoucha, A
    Robert, J
    Dega, H
    Lounis, N
    Jarlier, V
    Grosset, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3109 - 3112
  • [4] Activities of several antimicrobials against Mycobacterium ulcerans infection in mice
    Dega, H
    Robert, J
    Bonnafous, P
    Jarlier, V
    Grosset, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2367 - 2372
  • [5] Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers
    Hafner, R
    Bethel, J
    Power, M
    Landry, B
    Banach, M
    Mole, L
    Standiford, HC
    Follansbee, S
    Kumar, P
    Raasch, R
    Cohn, D
    Mushatt, D
    Drusano, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) : 631 - 639
  • [6] DISSEMINATED OSTEOMYELITIS FROM MYCOBACTERIUM-ULCERANS AFTER A SNAKEBITE
    HOFER, M
    HIRSCHEL, B
    KIRSCHNER, P
    BEGHETTI, M
    KAELIN, A
    SIEGRIST, CA
    SUTER, S
    TESKE, A
    BOTTGER, EC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) : 1007 - 1009
  • [7] JACYK W, 1978, DERMATOL PERISTA MEX, V22, P36
  • [8] Disseminated Mycobacterium ulcerans disease in an HIV-positive patient:: a case study
    Johnson, RC
    Ifebe, D
    Hans-Moevi, A
    Kestens, L
    Houessou, R
    Guédénon, A
    Meyers, WM
    Portaels, F
    [J]. AIDS, 2002, 16 (12) : 1704 - 1705
  • [9] KRIEG RE, 1979, AVIAT SPACE ENVIR MD, V50, P888
  • [10] Lagarrigue V, 2000, Med Trop (Mars), V60, P262